Insilico Medicine scores $110M for AI-enabled drug discovery
Tech-enabled drug discovery company Insilico Medicine secured $110 million in an oversubscribed Series E funding round. A large equity fund of Value Partners Group, an asset management firm in Asia, and new and existing investors participated in the …